These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 22245727)

  • 1. The nonreceptor-type tyrosine phosphatase PTPN13 is a tumor suppressor gene in non-small cell lung cancer.
    Scrima M; De Marco C; De Vita F; Fabiani F; Franco R; Pirozzi G; Rocco G; Malanga D; Viglietto G
    Am J Pathol; 2012 Mar; 180(3):1202-1214. PubMed ID: 22245727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-30e-5p promotes cell growth by targeting PTPN13 and indicates poor survival and recurrence in lung adenocarcinoma.
    Zhuang L; Shou T; Li K; Gao CL; Duan LC; Fang LZ; Zhang QY; Chen ZN; Zhang C; Yang ST; Li GF
    J Cell Mol Med; 2017 Nov; 21(11):2852-2862. PubMed ID: 28653805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PTPN13 acts as a tumor suppressor in clear cell renal cell carcinoma by inactivating Akt signaling.
    Long Q; Sun J; Lv J; Liang Y; Li H; Li X
    Exp Cell Res; 2020 Nov; 396(1):112286. PubMed ID: 32919955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protein tyrosine phosphatase PTPN13 negatively regulates Her2/ErbB2 malignant signaling.
    Zhu JH; Chen R; Yi W; Cantin GT; Fearns C; Yang Y; Yates JR; Lee JD
    Oncogene; 2008 Apr; 27(18):2525-31. PubMed ID: 17982484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR-26a desensitizes non-small cell lung cancer cells to tyrosine kinase inhibitors by targeting PTPN13.
    Xu S; Wang T; Yang Z; Li Y; Li W; Wang T; Wang S; Jia L; Zhang S; Li S
    Oncotarget; 2016 Jul; 7(29):45687-45701. PubMed ID: 27285768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of PTPN13 in invasion and metastasis of lung squamous cell carcinoma.
    Han X; Xue L; Zhou L; Gong L; Zhu S; Yao L; Wang S; Lan M; Li Y; Zhang W
    Exp Mol Pathol; 2013 Dec; 95(3):270-5. PubMed ID: 23906871
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PTPN13 induces cell junction stabilization and inhibits mammary tumor invasiveness.
    Hamyeh M; Bernex F; Larive RM; Naldi A; Urbach S; Simony-Lafontaine J; Puech C; Bakhache W; Solassol J; Coopman PJ; Hendriks WJAJ; Freiss G
    Theranostics; 2020; 10(3):1016-1032. PubMed ID: 31938048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ErbB2, EphrinB1, Src kinase and PTPN13 signaling complex regulates MAP kinase signaling in human cancers.
    Vermeer PD; Bell M; Lee K; Vermeer DW; Wieking BG; Bilal E; Bhanot G; Drapkin RI; Ganesan S; Klingelhutz AJ; Hendriks WJ; Lee JH
    PLoS One; 2012; 7(1):e30447. PubMed ID: 22279592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impaired PTPN13 phosphatase activity in spontaneous or HPV-induced squamous cell carcinomas potentiates oncogene signaling through the MAP kinase pathway.
    Hoover AC; Strand GL; Nowicki PN; Anderson ME; Vermeer PD; Klingelhutz AJ; Bossler AD; Pottala JV; Hendriks WJ; Lee JH
    Oncogene; 2009 Nov; 28(45):3960-70. PubMed ID: 19734941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paired box 5 is a frequently methylated lung cancer tumour suppressor gene interfering β-catenin signalling and GADD45G expression.
    Zhao L; Li S; Gan L; Li C; Qiu Z; Feng Y; Li J; Li L; Li C; Peng W; Xu C; Wang Z; Hui T; Ren G; Tao Q; Xiang T
    J Cell Mol Med; 2016 May; 20(5):842-54. PubMed ID: 26843424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumour-suppressive role of PTPN13 in hepatocellular carcinoma and its clinical significance.
    Zhan H; Jiang J; Luo C; Sun Q; Ke A; Sun C; Hu J; Hu Z; Hu B; Zhu K; Fan J; Zhou J; Huang X
    Tumour Biol; 2016 Jul; 37(7):9691-8. PubMed ID: 26801674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chloroquine in combination with aptamer-modified nanocomplexes for tumor vessel normalization and efficient erlotinib/Survivin shRNA co-delivery to overcome drug resistance in EGFR-mutated non-small cell lung cancer.
    Lv T; Li Z; Xu L; Zhang Y; Chen H; Gao Y
    Acta Biomater; 2018 Aug; 76():257-274. PubMed ID: 29960010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein tyrosine phosphatase PTPN3 inhibits lung cancer cell proliferation and migration by promoting EGFR endocytic degradation.
    Li MY; Lai PL; Chou YT; Chi AP; Mi YZ; Khoo KH; Chang GD; Wu CW; Meng TC; Chen GC
    Oncogene; 2015 Jul; 34(29):3791-803. PubMed ID: 25263444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The canonical TGF-β/Smad signalling pathway is involved in PD-L1-induced primary resistance to EGFR-TKIs in EGFR-mutant non-small-cell lung cancer.
    Zhang Y; Zeng Y; Liu T; Du W; Zhu J; Liu Z; Huang JA
    Respir Res; 2019 Jul; 20(1):164. PubMed ID: 31331328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Signal transducer and activator of transcription 3 as molecular therapy for non-small-cell lung cancer.
    Wang CY; Chao TT; Tai WT; Chang FY; Su WP; Chen YL; Chen PT; Weng CY; Yuan A; Shiau CW; Yu CJ; Chen KF
    J Thorac Oncol; 2014 Apr; 9(4):488-96. PubMed ID: 24736071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tyr1068-phosphorylated epidermal growth factor receptor (EGFR) predicts cancer stem cell targeting by erlotinib in preclinical models of wild-type EGFR lung cancer.
    Sette G; Salvati V; Mottolese M; Visca P; Gallo E; Fecchi K; Pilozzi E; Duranti E; Policicchio E; Tartaglia M; Milella M; De Maria R; Eramo A
    Cell Death Dis; 2015 Aug; 6(8):e1850. PubMed ID: 26247735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stat3 inhibits PTPN13 expression in squamous cell lung carcinoma through recruitment of HDAC5.
    Han XJ; Xue L; Gong L; Zhu SJ; Yao L; Wang SM; Lan M; Zhang W; Li YH
    Biomed Res Int; 2013; 2013():468963. PubMed ID: 24191246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EGFR phosphorylates and inhibits lung tumor suppressor GPRC5A in lung cancer.
    Lin X; Zhong S; Ye X; Liao Y; Yao F; Yang X; Sun B; Zhang J; Li Q; Gao Y; Wang Y; Liu J; Han B; Chin YE; Zhou BP; Deng J
    Mol Cancer; 2014 Oct; 13():233. PubMed ID: 25311788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PTPL1/PTPN13 regulates breast cancer cell aggressiveness through direct inactivation of Src kinase.
    Glondu-Lassis M; Dromard M; Lacroix-Triki M; Nirdé P; Puech C; Knani D; Chalbos D; Freiss G
    Cancer Res; 2010 Jun; 70(12):5116-26. PubMed ID: 20501847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dual Role of the PTPN13 Tyrosine Phosphatase in Cancer.
    Mcheik S; Aptecar L; Coopman P; D'Hondt V; Freiss G
    Biomolecules; 2020 Dec; 10(12):. PubMed ID: 33322542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.